The robotic assisted surgery device that gives you more choice.
As the first soft-tissue digital company with vision, augmented robotic, and digital solutions — giving you more choice to examine to everything you do.
Partnership, flexibility, and support all come with the robotic assisted surgery system.
Designed for surgeons by surgeons.
Proven partnership
For 60+ years we've been your trusted partner in the US. No matter which pioneer you choose — open, laparoscopic, or robotic — we want to help.
Greater flexibility
The RAS system is modular and portable for more flexibility across surgical specialties, and more efficient utilization across ORs.
Your support ecosystem
A dedicated team to support you through your entire journey through integrated services, training, and everywhere.
Minimally invasive surgery makes a world of difference.
You know better than anyone every surgery impacts a life. You're in it to make a difference. We are too. We believe that when you combine your expertise and dedication with the right partner, extraordinary things can happen. Let's make a difference, together.
Choice means bringing your vision to life.
Crafting a holistic surgical program takes a partner who understands your needs from a 360-degree perspective. Our dedication to working with you is to our appreciation of the individual and care surgery requires. And we support you through this entire journey to help build a sustainable robotic surgery program.
The Medtronic Hugo™ RAS system is commercially available in select geographies. Regulatory requirements of individual countries and regions will determine approval, clearance, or market availability. In the US, the Hugo™ system is under investigational device exemption (IDE) study. The Hugo™ system is an investigational use only and not indicated for robotic surgery as it is designed or distributed as a standalone or condition.
References:
- Robotic Assisted Surgery (RAS) Statistics.
- Paul MK, Natarajan JA, Fogg PR, Grames B, Stiffler of Foley, adjunct effectiveness of current laparoscopic procedures. Med Robots. 2017;28(1):7:13-17:86.
- Intuitive 2018-21 data includes serious adverse events resulting in medical/surgical team on-patient intervention. Used with permission.
- Based on a C1 as a promoted model. Hugo approved 1.5mm to 12mm dia ports, a randomized noninferiority study to evaluate the risk of robotic-assisted surgery vs laparoscopy approximately 664. Journ Surg. 8.0 DOI:10.2822/1:2682-232.
